Pentoxifylline effect in serum C-Reactive Protein (CRP) Concentration level in hemodialysis patients
Not Applicable
- Conditions
- End stage renal desease patients who underwent hemodialysis treatment.Chronic kidney disease, stage 5
- Registration Number
- IRCT2016032722540N2
- Lead Sponsor
- Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
Arteriovenous fistula as vascular access, Hemodialysis patients at least 2 months prior trial.
Exclusion criteria: Chronic active liver disease, Any infectious disease 2 months before the study, Failed kidney graft, Hypersensitivity to PTX or other methylxanthines, Hemorrhage/clotting disorders, Risk for worsening pre-existing cardiac arrhythmias or arterial hypotension, Treatment with antibiotics, non-steroidal anti-inflammatory drugs, steroids, immunosuppressives, statins or PTX 3 months previous to the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum CRP concentrations. Timepoint: At 0, 2 and 4 months of intervention. Method of measurement: Serum CRP concentrations.
- Secondary Outcome Measures
Name Time Method